Introduction {#Sec1}
============

Long preoperative fasting has been a standard practice for patients undergoing elective surgery to avoid vomiting and pulmonary aspiration during anesthesia induction. However, in the 1990s, physicians and scientists in Western countries started to question whether long preoperative fasting might be increasing the incidence of dehydration and perioperative complications. In 1999, the American Society of Anesthesiologists (ASA) issued a practice guideline \[[@CR1]\] for preoperative fasting in which patients (except those with delayed gastric emptying) are allowed to have clear fluids (water, fruit juices without pulp, carbonated beverages, clear tea, and black coffee) until 2 h before surgery. European anesthesia societies have established similar guidelines \[[@CR2]--[@CR4]\]. A survey of 258 medical institutions in five northern European countries revealed that most of them allowed clear fluids up to a median of 2 h before surgery \[[@CR5]\]. In contrast, a 2003 nationwide survey of preoperative fasting in Japanese anesthesia-teaching hospitals revealed that most hospitals used long preoperative fasting: the median duration of fasting in adults was 9 h before morning surgery and 6 h before afternoon surgery \[[@CR6]\].

Perioperative fluid and electrolyte balance should be managed so that patients enter the operating room with normal fluid and electrolyte balance, instead of starting the procedure at anesthesia induction \[[@CR7]\]. For surgical patients, recent Japanese studies have shown that oral rehydration therapy is a safe and effective method for managing preoperative water and electrolyte intake \[[@CR8]\], but this result still needs to be confirmed by larger randomized clinical trials.

Therefore, we conducted a multicenter clinical study to investigate the safety and efficacy of oral rehydration therapy until 2 h before surgery by using an oral rehydration solution (ORS). The objective of our study was to improve current preoperative fasting practice and to evaluate the efficacy of preoperative oral rehydration therapy.

Patients and methods {#Sec2}
====================

The study was conducted at six institutions: Tokai University Hospital, Saitama Medical University Saitama Medical Center, Jichi Medical University Saitama Medical Center, Nippon Medical School Hospital, Kyorin University Hospital, and Kawasaki Medical School Hospital. The study was approved by the Institutional Ethics Committee of each institution and was conducted in accordance with Declaration of Helsinki-Ethical Principles for Medical Research Involving Human Subjects and with the Ethical Guidelines for Clinical Research issued by Ministry of Health, Labour, and Welfare.

Patients {#Sec3}
--------

Patients were eligible for the study if they were between 20 and 80 years old; scheduled to have elective, morning surgery requiring general anesthesia between January 2010 and March 2011; and were ASA physical status I or II. Exclusion criteria were dysphagia, esophagostenosis, the inability to take food orally as a result of neurological and other disorders; gastrointestinal obstruction; renal dysfunction (a creatinine clearance of 20 ml min^−1^ or lower or dialysis); electrolyte abnormalities; body mass index (BMI) of 35 kg m^−2^ or larger; and pregnancy. Also excluded were patients receiving intravenous fluid for any reasons preoperatively; a premedication; an H~2~ receptor blocker or a proton pump inhibitor; a diuretic; or steroids. Patients otherwise deemed unsuitable for the study were also excluded.

Experimental plan {#Sec4}
-----------------

Before the study, written informed consents were obtained after the patients were extensively informed about the study procedure. The enrolled patients were assigned at random to either an ORS group or to a fasting group at each institution. Randomization was performed according to a computer-generated schedule with a permuted-block design.

Primary endpoints were gastric volume and its pH immediately after anesthesia induction. Secondary endpoints included the incidence of vomiting and aspiration associated with anesthesia induction, the relationships of gastric fluid volume and with age and with BMI in the ORS group, the effect of rehydration, vital signs, and the patient's comfort.

Patients in both groups were allowed to have food or drink until 2100 on the night before surgery (Fig. [1](#Fig1){ref-type="fig"}). Patients in the ORS group consumed up to 1,000 ml of ORS (OS-1; Otsuka Pharmaceutical Factory, Tokushima, Japan; Table [1](#Tab1){ref-type="table"}): 500 ml between 2100 the night before surgery and the time they woke up the next morning and 500 ml in the morning of surgery up until 2 h before surgery. Patients in the fasting group started fasting at 2100 the night before surgery. Patients in either group who needed to take medications orally before surgery were allowed to do so with 20--50 ml water until 2 h before surgery. Types of surgery, anesthesia methods, and intraoperative fluid management were at the discretion of each institution.Fig. 1Schedule of treatment and data collection in the study that tested the safety and efficacy of oral rehydration therapy until 2 h before surgery under general anesthesia. *ORS group*, oral rehydration solution group (OS-1; oral rehydration solution: Otsuka Pharmaceutical Factory, Tokushima, Japan) Table 1Composition of the oral rehydration solution (OS-1) used to test the safety and efficacy of oral rehydration therapy until 2 h before surgeryVolume (ml)500Energy (kcal)50Carbohydrate (%)2.5 (glucose, 1.8)Electrolytes (mEq l^−1^) Sodium50 Potassium20 Magnesium2 Chloride50 Lactate31 Phosphorus (mmol l^−1^)2pH3.9Osmolarity (mOsm l^−1^)About 270OS-1, Otsuka Pharmaceutical Factory, Tokushima, Japan

Gastric fluid volume and gastric fluid pH of the patients were measured in supine position immediately after anesthesia induction. Any incidences of vomiting or aspiration were recorded. Patients were intubated by mouth or nose with a nasogastric tube (the tube was inserted until 60 cm of the tube was placed inside the body). Correct placement of the tube in the stomach was confirmed by hearing the air with a stethoscope, and gastric contents were suctioned at 60, 55, and 50 cm from the top of the catheter with a catheter syringe \[[@CR9]\]. This procedure was repeated three times. Gastric fluid was sampled by the same person at each institution, whenever possible. Gastric fluid pH was measured by SRL (SRL, Inc., Clinical Laboratory Testing Company, Tokyo, Japan). We evaluated the efficacy of the ORS to provide hydration and electrolytes by measuring the fractional excretion of sodium (FENa), the fractional excretion of urea nitrogen (FEUN), ratio of serum urea nitrogen to serum creatinine, hematocrit, serum total protein, serum albumin, serum electrolytes (sodium, potassium, and chlorine), urine output (between 2100 the night before surgery and start of surgery and during surgery), and the amount of vasoconstrictors or intravenous solutions used during surgery. Blood was taken immediately after anesthesia induction, and the first urine sample was taken after a urinary catheter was placed. Patients were asked whether they were thirsty, hungry, or anxious before they entered the operating room. They were also asked twice whether they were nauseous or had vomited, on the night after surgery and at noon the next day. Patients completed the questionnaire form. Vital signs (blood pressure, pulse rate, and body temperature) were measured after dinner the night before surgery; before entering the operating room; at 5, 10, 15, 30, and 60 min after anesthetic induction; and every 1 h afterwards. Blood and urine samples were tested by SRL.

Statistical methods {#Sec5}
-------------------

In this noninferiority study, gastric volumes were compared between the ORS group and the fasting group. Sample size calculation was based on a Cochrane review of studies on preoperative fasting and assumed that between-group difference in the residual gastric volume was 0 ml, noninferiority margin was +8 ml, standard deviation of residual gastric volume was 25 ml, two-tailed significance level was 0.05, and power was 0.80 \[[@CR10]\]. The needed sample size was 122 per group, which was increased to 150 per group to allow for withdrawals.

For the primary endpoint, mean, standard deviation, maximum, median, minimum, third quartile, and first quartile of the gastric fluid volume and gastric fluid pH were calculated for each group. For the secondary endpoints, mean standard deviation, maximum, median, minimum, third quartile, and first quartile of FENa and FEUN were calculated. For other results, mean and standard deviation were calculated for each group. The SAS statistical software package, version 9.1.3 (SAS Institute Japan, Tokyo, Japan), was used for statistical analyses. Differences were considered statistically significant at the 0.05 level for both unpaired *t* tests and Chi-square test. Differences in patient demographic characteristics were considered significant at the 0.15 level. Pearson product-moment correlation coefficient was used for correlation analyses. Analysis of variance was performed on gastric fluid volume and gastric fluid pH with institutions and groups used as factors to check for confounding.

Results {#Sec6}
=======

Of 300 patients enrolled, 150 were assigned to the ORS group and 150 to the fasting group. Of these, 26 withdrew, leaving 135 in the ORS group and 139 in the fasting group (Fig. [2](#Fig2){ref-type="fig"}). Patients underwent otorhinolaryngological surgery, orthopedic/plastic surgery, gynecological surgery, breast and thyroid surgery, or thoracic surgery. BMI was significantly different between groups, but the difference was not clinically important. Other demographic characteristics did not differ significantly between groups (Table [2](#Tab2){ref-type="table"}). Mean (SD) ORS intake in the ORS group was 414 (137) ml the night before surgery and 398 (143) ml on the morning of surgery.Fig. 2Flow diagram of the study progress and disposition of 300 patients enrolled in the study that tested the safety and efficacy of oral rehydration therapy until 2 h before surgery Table 2Demographic and system organ class of patients in a study testing the safety and efficacy of oral rehydration therapy until 2 h before surgeryORS groupFasting group*P*Sex, men/women36/9939/100NS^a^Age, mean (SD) (years)47.9 (13.5)48.6 (14.9)NS^b^Body mass index, mean (SD) (kg m^−2^)22.5 (3.1)23.1 (4.0)0.14^b^ASA physical status (*n*)NS^a^ I8891 II4748System organ class (*n*)NS^a^ Neoplasms benign, malignant, and unspecified9091 Infections and infestations1411 Musculoskeletal and connective tissue disorders1013 Reproductive system and breast disorders64 Injury, poisoning, and procedural complications48 Surgical and medical procedures35 Respiratory, thoracic, and mediastinal disorders24 Endocrine disorders22 Gastrointestinal disorders20 Nervous system disorders11 Skin and subcutaneous tissue disorders10Duration of surgery, mean (SD) (min)155.3 (113.0)152.5 (99.9)NS^b^Duration of anesthesia, mean (SD) (min)213.7 (120.2)212.1 (105.2)NS^b^Intraoperative blood loss, mean (SD) (ml)366.8 (751.0)295.8 (379.3)NS^b^*ASA* American Society of Anesthesiologists,*ORS* oral rehydration solution^a^Chi-square test, α = 0.15^b^Unpaired *t* test, α = 0.15

Mean (SD) gastric fluid volume at anesthesia induction did not differ significantly between groups (*P* = 0.30): 15.1 (14.0) ml (range, 0--60 ml) in the ORS group and 17.5 (23.2) ml (range, 0--155 ml) in the fasting group (Fig. [3](#Fig3){ref-type="fig"}). The mean difference between the ORS group and fasting group was −2.5 ml. The 95% confidence interval ranged from −7.1 to +2.2 ml and did not include the noninferior limit of +8 ml. Mean (SD) gastric fluid pH was 2.1 (1.9) in the ORS group and 2.2 (2.0) in the fasting group; there was no significant difference between groups (*P* = 0.59; Table [3](#Tab3){ref-type="table"}). Analysis of variance revealed no confounding between institutions and groups on gastric fluid volume or gastric fluid pH (data not reported). No incidence of vomiting or aspiration was reported. A statistically significant but clinically unimportant inverse relationship was seen between age and gastric fluid volume in the ORS group (*R* ^2^ = 0.0809, *P* = 0.001); the older the patient, the smaller the gastric fluid volume was to become. There was no correlation between the BMI and gastric fluid volume (*R* ^2^ = 0.0003, *P* = 0.85).Fig. 3Gastric fluid volume and gastric fluid pH immediately after anesthesia induction in patients who received an oral rehydration solution and those who fasted overnight. (Plots show medians, ranges, and interquartile ranges.) Statistical analysis: unpaired *t* test (α = 0.05) Table 3Physiological characteristics of patients in a study testing the safety and efficacy of oral rehydration therapy until 2 h before surgeryCharacteristic^a^ORS groupFasting group*P* ^b^Blood urea nitrogen/serum creatinine ratio, mean (SD)17.9 (4.9)19.7 (5.2)\<0.01Hematocrit, mean (SD) (%)40.2 (4.9)40.4 (5.0)NSSerum total protein, mean (SD) (g dl^−1^)7.0 (0.6)7.0 (0.7)NSSerum albumin, mean (SD) (g dl^−1^)4.2 (0.5)4.1 (0.5)NSSerum sodium, mean (SD) (mEq l^−1^)140.5 (1.8)140.5 (1.9)NSSerum potassium, mean (SD) (mEq l^−1^)4.1 (0.3)4.1 (0.3)NSSerum chloride, mean (SD) (mEq l^−1^)105.6 (1.8)105.6 (2.1)NSUrine volume, mean (SD) (ml kg^−1^) Between night before surgery and start of surgery15.3 (8.2)10.6 (5.4)\<0.001 Between start of surgery and 1 h later2.1 (2.3)1.4 (1.8)\<0.01 Between 1 and 2 h later3.2 (3.8)2.8 (3.7)NS Between 2 and 3 h later3.7 (4.3)2.8 (3.6)NS Between 3 and 4 h later3.1 (4.6)2.4 (2.0)NSDose of vasopressor during surgery Ephedrine hydrochloride, mean (SD) (mg)12.5 (9.5)11.0 (8.6)NS Phenylephrine hydrochloride, mean (SD) (mg)0.3 (0.3)0.4 (0.2)NSVolume of fluid during surgery Crystalloid solution, mean (SD) (ml kg^−1^ h^−1^)9.0 (3.6)8.9 (3.6)NS Colloid solution, mean (SD) (ml kg^−1^ h^−1^)0.8 (1.5)0.8 (1.5)NS^a^Measurements taken immediately before anesthesia induction unless otherwise indicated^b^Unpaired *t* test, α = 0.05

In the ORS group, mean FENa and FEUN immediately after anesthesia induction were both significantly greater than those in the fasting group (*P* \< 0.001 for both variables): mean (SD) FENa was 0.94% (0.45%) in the ORS group, 0.64% (0.41%) in the fasting group, and mean (SD) FEUN was 33.7% (8.2%) in the ORS group and 27.2% (9.2%) in the fasting group (Fig. [4](#Fig4){ref-type="fig"}). The mean (SD) ratio of serum urea nitrogen to serum creatinine was significantly (*P* \< 0.01) smaller in the ORS group \[17.9 (4.9)\] than in the fasting group \[19.7 (5.2)\]. The urine output between the night before surgery and start of surgery and up to 1 h after surgery was significantly greater in the ORS group (*P* \< 0.001, 0.01). None of the physiological characteristics or vital signs differed between groups (Table [3](#Tab3){ref-type="table"}). Both thirst and hunger before surgery were reported by significantly fewer patients in the ORS group (*P* \< 0.001, 0.01), although the proportion of those reporting perioperative anxiety, nausea, and vomiting did not differ significantly between groups (Table [4](#Tab4){ref-type="table"}).Fig. 4Fractional excretion of sodium (*FENa*) and fractional excretion of urea nitrogen (*FEUN*) immediately after anesthesia induction in patients who received an oral rehydration solution and those who fasted overnight. (Plots show medians, ranges, and interquartile ranges.) Statistical analysis: unpaired *t* test α = 0.05). FENa = (urine sodium × serum creatinine)/(serum sodium ×urine creatinine), *FEUN* = (urine urea nitrogen × serum creatinine)/(blood urea nitrogen × urine creatinine) Table 4Sensations reported at key times by patients in a study testing the safety and efficacy of oral rehydration therapy until 2 h before surgerySensationORS groupFasting group*P* ^a^Before entering the operating room Dry mouth, yes/no/difficult to answer (%)11.9/83.0/5.265.0/28.5/6.6\<0.001 Hunger, yes/no/difficult to answer (%)32.6/56.3/11.152.6/35.8/11.7\<0.01 Anxiety, yes/no/difficult to answer (%)42.5/43.3/14.248.9/37.2/13.9NSNight on the day of surgery Nausea, yes/no (%)27.8/72.224.6/75.4NS Vomiting, yes/no (%)17.3/82.714.2/85.8NSAfternoon on the day after surgery Nausea, yes/no (%)15.3/84.720.3/79.7NS Vomiting, yes/no (%)9.2/90.814.2/85.8NS^a^Chi-square test, α = 0.05

Discussion {#Sec7}
==========

In the present study, gastric fluid volume in the ORS group was not inferior to that in the fasting group. Others have reported that gastric fluid volume was smaller in patients who received clear fluids until 2--3 h before surgery than it was in fasting patients, and our study results showed the same trends \[[@CR10]\]. If the gastric fluid volume is 200 ml or larger when anesthesia is induced, the patient is at increased risk for vomiting and aspiration \[[@CR2]\]. However, no patient had a gastric volume greater than 200 ml: the maximum volume was 60 ml in the ORS group and 155 ml in the fasting group. Gastric fluid pH did not differ significantly between the groups. Thus, oral rehydration therapy is feasible with sufficient safety margin for up to 2 h before surgery. Perioperative fasting guidelines in adults and children issued by the European Society of Anaesthesiology state that patients can safely drink carbohydrate-rich fluids up to 2 h before surgery. However, the evidence for safety is derived from studies of products specifically developed for perioperative use (predominantly maltodextrins); not all carbohydrates are necessarily safe \[[@CR4]\]. We also believe beverages with clearly established evidence of safety should be given to patients undergoing surgery.

We excluded patients aged 80 years or older, severely obese patients (BMI ≥ 35 kg m^−2^), and pregnant women. However, gastric fluid volume was slightly inversely related to age in the ORS group, and gastric fluid volume was not related to BMI. In studies with elderly patients, clear fluids intake until 2 h before surgery did not cause problems \[[@CR11], [@CR12]\]. In studies with obese patients (BMI \> 30 kg m^−2^), the gastric fluid volume in patients who received clear fluids until 2 h before surgery was similar to that in fasting patients \[[@CR13]\]. A study of obese pregnant women showed that the gastric fluid volume 1 h after they drank 300 ml water was the same as the volume when fasting before drinking water \[[@CR14]\]. Practice Guidelines for Obstetric Anesthesia issued by the ASA also state that patients can safely receive clear fluids until 2 h before surgery, except those who at increased risk for operative delivery, such as a non-reassuring fetal heart rate pattern \[[@CR15]\]. Therefore, it seems reasonable that oral rehydration therapy can be safely administered to elderly, obese, or pregnant patients up to 2 h before surgery.

Both FENa and FEUN, which we used to evaluate the adequacy of hydration and electrolytes provided by the ORS, indicate the percentages of sodium and urea nitrogen that are filtrated through the glomerulus and ultimately excreted to the urine; that is, they are used as an index for renal blood flow \[[@CR16], [@CR17]\]. Both parameters decrease in dehydrated patients with normal renal function. (We excluded patients with a creatinine clearance of 20 ml min^−1^ or less or those on dialysis.) Our results revealed both FENa and FEUN in the fasting group were significantly lower than those in the ORS group. Also, the ratio of serum urea nitrogen to serum creatinine was significantly higher, and urine output before surgery and during the first hour of surgery were significantly lower in the fasting group. Furthermore, before surgery, 65.0% in the fasting group reported being thirsty. Thus, fasting starting on the night before surgery can result in a decreased amount of water in the body, and the decrease would have been prevented with oral rehydration therapy. The amount of vasoconstrictors or intravenous solutions used during surgery did not differ significantly between groups. The following mechanisms can be proposed: there were many confounding factors including the type of surgery, methods of anesthesia, and type and administration rate of intravenous fluids. Although FENa, FEUN, and serum biochemical profiles suggested the positive effects of ORS, actual effect on the amount of water in the body could have been minimal.

In our study, the only apparent clinical advantages were that patients in the ORS group reported being less thirsty and hungry. However, patient comfort is among the important clinical indices in the era of fast-track surgery. The mean (SD) ORS intake between the night before surgery and 2 h before surgery was 812 (240) ml, which was larger than expected and indicates the ORS is well tolerated. Also, there were few incidences of nausea or vomiting associated with ORS intake after surgery.

The safety and efficacy of the ORS for mildly to moderately dehydrated patients have already been studied \[[@CR18]--[@CR20]\]. Our study provided further supporting data regarding the safety and efficacy of the ORS in preoperative patients.

Limitations of the study {#Sec8}
------------------------

We did not include high-risk patients, patients with ASA physical status III or higher, and the safety and efficacy of the ORS in these patients are still unknown. Also, the effects of the supplemental electrolytes and glucose cannot be differentiated from those of rehydration. Therefore, to further investigate the true benefits of oral rehydration with the ORS, another study should be undertaken with water as a control arm under the specified type of surgery and methods of anesthesia and intravenous administration maintenance.

Conclusions {#Sec9}
===========

We investigated the safety and efficacy of oral rehydration therapy until 2 h before surgery in a multicenter randomized controlled clinical study. Gastric volume in the ORS group immediately after anesthesia induction was not inferior to that in the fasting group, and no significant difference in pH was found between groups. Our study supports that oral rehydration therapy until 2 h before surgery is safe. Thus, healthcare professionals should also be encouraged to use oral rehydration therapy until 2 h before surgery to maintain the amount of water in the body and electrolytes and to improve the patient's comfort.
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